Neurology News

  • AAN Phase 3 Trials Positive for Erenumab in Migraine Prevention Both STRIVE and ARISE phase 3 trials met their primary outcomes, showing greater reductions in monthly migraine days for patients with episodic migraine treated with erenumab vs those receiving placebo.
 

Columnists

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Mumps Cases Surge in USMumps is making a comeback. While Texas is experiencing a 20-year high in mumps cases, public health officials report nearly 2,000 cases across 42 states and the District of Columbia since January.
  • Troubles of the Billionaire 'Moonshot' DoctorOnly months after being in the spotlight as a potential player in the Trump administration, a wealthy doctor is beset by a rash of controversies
  • Phase 3 Trials Positive for Erenumab in Migraine PreventionBoth STRIVE and ARISE phase 3 trials met their primary outcomes, showing greater reductions in monthly migraine days for patients with episodic migraine treated with erenumab vs those receiving placebo.

Perspective

Business of Medicine

  • Should Patients Get a Money-Back Guarantee? It's been suggested that health clinics offer rebates to patients who are unhappy with care and amenities, such as office wait times and unappetizing meals. That suggestion infuriates physicians.
  • Five Doctors Tell 'How I Survived After Being Sued' For a physician, getting sued for malpractice is extremely personal. Physicians who were sued describe the range of emotions they felt, and how it changed their lives and the way they view patients.

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape